Table 1.
Participant characteristics.
Variable | Participant type
|
|
---|---|---|
Healthy control (n = 39) | LBP (n = 37) | |
Age (years)* | 30.9 ± 8.26 | 35.2 ± 9.86 |
Gender (% female)* | 71.8 | 48.6 |
Race (%) | ||
White | 87.2 | 78.4 |
African-American | 10.3 | 8.1 |
Ethnicity (% non-Hispanic) | 94.9 | 89.2 |
Chronic pain duration (median, in months) | 70.2 | |
Past month chronic pain intensity (0–100) | 44.1 ± 16.91 | |
Resting plasma BE (ng/mL) | 1.5 ± 2.41 | 1.8 ± 2.57 |
BDI** | 2.8 ± 3.04 | 7.5 ± 5.88 |
STAI** | 32.1 ± 6.97 | 38.1 ± 8.38 |
PANAS–Negative Affect | 15.4 ± 3.99 | 16.8 ± 4.20 |
Values are presented as percentages or means ± SD. BDI, Beck Depression Inventory; BE, beta-endorphin; LBP, chronic low back pain; PANAS, Positive and Negative Affect Scales; SD, standard deviation; STAI, State Trait Anxiety Inventory.
p < 0.05.
p < 0.01.